View Archive »
About The Cover
The cover for issue 71 of Oncotarget features Figure 1B, "Schematic representation to illustrate the differential binding and internalization of low affinity EGFR-ADC on normal cells versus tumor cells that express higher level of the receptors," by Wong, et al.
|
|
Table of Contents
Editorial
|
| CXCR4 antagonists for treatment of breast cancer |
|
https://doi.org/10.18632/oncotarget.26090
|
| 33442-33443 |
|
| Boosting chemokine receptor recycling: an elixir of life for chronic lymphocytic leukemia |
|
https://doi.org/10.18632/oncotarget.26099
|
| 33444-33445 |
Priority Research Papers
|
| RN765C a low affinity EGFR antibody drug conjugate with potent antitumor activity in preclinical solid tumor models |
|
https://doi.org/10.18632/oncotarget.26002
|
| 33446-33458 |
Research Papers
|
| TRPV2 is a novel biomarker and therapeutic target in triple negative breast cancer |
|
https://doi.org/10.18632/oncotarget.9663
|
| 33459-33470 |
|
| Silencing of the nucleocytoplasmic shuttling protein karyopherin a2 promotes cellcycle arrest and apoptosis in glioblastoma multiforme |
|
https://doi.org/10.18632/oncotarget.26033
|
| 33471-33481 |
|
| Generation and characteristics of a novel “doublehit†high grade Bcell lymphoma cell line DHMy6 with MYC/IGH and BCL6/IGH gene arrangements and potential molecular targeted therapies |
|
https://doi.org/10.18632/oncotarget.26060
|
| 33482-33499 |
|
| Comparative proteomic analysis of cat eye syndrome critical region protein 1 function in tumorassociated macrophages and immune response regulation of glial tumors |
|
https://doi.org/10.18632/oncotarget.26063
|
| 33500-33514 |
|
| SSeCKS/Akap12 suppresses metastatic melanoma lung colonization by attenuating Srcmediated premetastatic niche crosstalk |
|
https://doi.org/10.18632/oncotarget.26067
|
| 33515-33527 |
|
| Clofarabinebased reduced intensity conditioning regimen with peripheral blood stem cell graft and posttransplant cyclophosphamide in adults with myeloid malignancies |
|
https://doi.org/10.18632/oncotarget.26083
|
| 33528-33535 |
|
| Intestinal epithelial Notch1 protects from colorectal mucinous adenocarcinoma |
|
https://doi.org/10.18632/oncotarget.26086
|
| 33536-33548 |
|
| The Akt/mTOR pathway in cancer stem/progenitor cells is a potential therapeutic target for glioblastoma and neuroblastoma |
|
https://doi.org/10.18632/oncotarget.26088
|
| 33549-33561 |
|
| Elucidating the novel BRCA1 function as a nongenomic metabolic restraint in ERpositive breast cancer cell lines |
|
https://doi.org/10.18632/oncotarget.26093
|
| 33562-33576 |
|
| MiR29b15p is altered in BRCA1 mutant tumours and is a biomarker in basallike breast cancer |
|
https://doi.org/10.18632/oncotarget.26094
|
| 33577-33588 |
|
| Adaptation to chronic exposure to sepantronium bromide YM155 a prototypical survivin suppressant is due to persistent DNA damageresponse in breast cancer cells |
|
https://doi.org/10.18632/oncotarget.26096
|
| 33589-33600 |
Reviews
|
| Active ginseng components in cognitive impairment: Therapeutic potential and prospects for delivery and clinical study |
|
https://doi.org/10.18632/oncotarget.26035
|
| 33601-33620 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLC
